Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11185592 Spirocyclic degronimers for target protein degradation

Patent 11185592 was granted and assigned to C4 Therapeutics on November, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 18 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 18 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12091397 Dihydroquinolinones for medical treatment
0
Edits on 31 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 27 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11851445 Compounds and uses thereof
0
Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+324 characters)
Article

Patent abstract

This invention provides compounds that have spirocyclic E3 Ubiquitin Ligase targeting moieties (Degrons), which can be used as is or linked to a targeting ligand for a protein that has been selected for in vivo degradation, and methods of use and compositions thereof as well as methods for their preparation.

Edits on 1 Nov, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Nov, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11802131 Glutarimides for medical treatment
Edits on 19 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11787800 BRD9 degraders and uses thereof
Edits on 5 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11773085 Methods and compounds for treating disorders
Edits on 27 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11767330 Citrate salt, pharmaceutical compositions, and methods of making and using the same
Edits on 6 Aug, 2023
"Resolve patent citation"
Golden AI profile picture
Golden AI
edited on 6 Aug, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
C4 Therapeutics
C4 Therapeutics
0
Current Assignee
C4 Therapeutics
C4 Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
111855920
Date of Patent
November 30, 2021
0
Patent Application Number
168822360
Date Filed
May 22, 2020
0
Patent Citations Received
‌
US Patent 11414416 Compounds and uses thereof
0
‌
US Patent 11560381 Compounds and uses thereof
0
Patent Primary Examiner
‌
Rei Tsang Shiao
0
Edits on 5 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11691972 Compounds for targeted degradation of BRD9
0
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1118559200
Edits on 7 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 7 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 11560381 Compounds and uses thereof
0
Edits on 26 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
C4 Therapeutics
C4 Therapeutics
0
Current Assignee
C4 Therapeutics
C4 Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
111855920
Date of Patent
November 30, 2021
0
Patent Application Number
168822360
Date Filed
May 22, 2020
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=111855920
Patent Citations Received
‌
US Patent 11414416 Compounds and uses thereof
0
‌
US Patent 11560381 Compounds and uses thereof
0
Patent Primary Examiner
‌
Rei Tsang Shiao
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Infobox
Patent Citations Received
‌
US Patent 11414416 Compounds and uses thereof
0
Edits on 25 Jan, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 25 Jan, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11560381 Compounds and uses thereof
0
Edits on 22 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
C4 Therapeutics
C4 Therapeutics
0
Current Assignee
C4 Therapeutics
C4 Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
111855920
Date of Patent
November 30, 2021
0
Patent Application Number
168822360
Date Filed
May 22, 2020
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=111855920
Patent Citations Received
‌
US Patent 11414416 Compounds and uses thereof
0
Patent Primary Examiner
‌
Rei Tsang Shiao
0
Edits on 17 Aug, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 17 Aug, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11414416 Compounds and uses thereof
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11185592
Edits on 2 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 2 Dec, 2021
Edits made to:
Infobox (+9 properties)
‌

 US Patent 11185592 Spirocyclic degronimers for target protein degradation

Infobox
Is a
Patent
Patent
Patent applicant
C4 Therapeutics
C4 Therapeutics
Current assignee
C4 Therapeutics
C4 Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11185592
Date of patent
November 30, 2021
Patent application number
16882236
Date Filed
May 22, 2020
Patent primary examiner
‌
Rei Tsang Shiao

Find more entities like US Patent 11185592 Spirocyclic degronimers for target protein degradation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.